Prevention of venous thromboembolism in 2020 and beyond
Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …
A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …
Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines
Z Zhai, C Li, Y Chen, G Gerotziafas… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …
[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report.
BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …
significant coagulopathy, that likely manifests in the form of both microthrombosis and …
[PDF][PDF] Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines
P Fontana, A Casini, H Robert-Ebadi, F Glauser… - Swiss medical …, 2020 - smw.ch
AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …
[HTML][HTML] Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
T Wang, R Chen, C Liu, W Liang, W Guan… - The Lancet …, 2020 - ncbi.nlm.nih.gov
Comment www. thelancet. com/haematology Vol 7 May 2020 e363 risk factors (aged 40
years or older, had hepatic failure (international normalised ratio> 1∙ 5), had severe renal …
years or older, had hepatic failure (international normalised ratio> 1∙ 5), had severe renal …
[HTML][HTML] Epidemiology of venous thromboembolism in Africa: a systematic review
Essentials• Venous thromboembolism (VTE) is among the three main causes of
cardiovascular disease worldwide.• This review is the first to summarize the epidemiology of …
cardiovascular disease worldwide.• This review is the first to summarize the epidemiology of …
Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic review and meta-analysis
Background: Preliminary evidence indicates that prophylactic-dose thromboprophylaxis may
be inadequate to control the increased risk of venous thromboembolism (VTE) in patients …
be inadequate to control the increased risk of venous thromboembolism (VTE) in patients …
[HTML][HTML] The prophylaxis of venous thromboembolism
A Encke, S Haas, I Kopp - Deutsches Ärzteblatt International, 2016 - ncbi.nlm.nih.gov
Background Venous thromboembolism (VTE) is the third most common cardiovascular
condition, after myocardial infarction and stroke. Prophylactic measures in accordance with …
condition, after myocardial infarction and stroke. Prophylactic measures in accordance with …